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Abstract: Climate change adaptation is receiving ever more attention in the literature and in practice.
Since available funds are not meeting adaptation needs, the question of how to allocate scarce
resources becomes pressing. Universal adaptation metrics promise to facilitate the allocation process
ex ante and the evaluation of projects ex post. Two such metrics have been proposed recently: Saved
Wealth (SW), measured in terms of money, and Saved Health (SH), gauged in terms of disability
adjusted life-years (DALYs). The paper analyzes this SWSH approach and shows that it is replete
with unresolved conceptual and normative-ethical problems, which are exemplary for universal
metrics seeking to combine concerns for equity and efficiency at once. The paper’s aim is to uncover
these issues, and its conclusion is modest: universal metrics such as SW and the DALY have to be
designed and used with great caution and further research is necessary.
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1. Introduction
As climate change adaptation is getting ever more attention in the literature and in
practice and since available funds are not meeting adaptation needs, the question of how
to allocate scarce resources becomes pressing. Hence, a central issue in the current debate
is the question of how to measure, aggregate, and compare the effects of climate change
adaptation projects ([1] (p. 7)). If these effects could be measured and aggregated into one
or a few general metrics, the latter could be applied within cost-effectiveness analysis (CEA)
to identify and prioritize the most efficient adaptation projects ex ante and to evaluate
their success ex post ([2] (p. 29)). Yet, since adaptation is an inherently multidimensional
and context-dependent phenomenon, a universally accepted definition of adaptation is
still lacking; it is therefore contested in the literature whether universal metrics for climate
change adaptation are feasible at all ([1] (p. 8), [2] (p. 31), [3] (p. 152)).
Michaelowa and colleagues have recently proposed two such metrics, though: Saved
Wealth (SW) and Saved Health (SH) [4–7] (For reasons of brevity, I will refer to these papers
as “Michaelowa et al.” or “Michaelowa and colleagues” in the following text, since Axel
Michaelowa is the only author involved in all the papers considered. Although the papers
differ in their specific content, I take it that there is sufficient common ground to warrant this
way of speaking). They define the aim of adaptation in rather general terms as improving
the “well-being of persons and countries” ([5] (p. 110) and operationalize it by means of the
three indicators (I will use the terms “metric” and “indicator” interchangeably): absolute
economic savings and relative economic savings on the one hand (SW) and human health
and lives saved on the other (SH). (Stadelmann et al. [5] only tackle human lives saved.
Yet, for this purpose, counting DALYs prohibited by some policy is neither necessary nor
sufficient. I will return to this issue in Section 4.) Taking into account the relative economic
savings is supposed to ameliorate some ethically troublesome implications of cost–benefit
analysis (CBA). While the latter only focuses on the sum of monetary benefits saved and
is thus higher the wealthier a community is, the same amount of benefits constitutes a
larger saving relative to the income of poorer communities. Hence, SW is supposed to
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incorporate concerns for vulnerability ([6] (p. 2150)). SH, in turn, consists in the number of
disability-adjusted life-years (DALYs) prohibited by a project. Stadelmann and colleagues
endorse the DALY, especially because a non-monetary measure of health benefits allows to
circumvent the “endless political debates about an equitable valuation of human life and
health” ([6] (p. 2149)), which are “fraught with ethical and political challenges” ([7] (p. 67);
see also [4], (p. 9), [6], (p. 2152)). In general, Michaelowa and colleagues seem anxious
to be as normatively modest as possible in formulating their approach and stress several
times that they do not seek to tackle ethical questions, which, they argue, call for political
decisions ([5] (p. 113), [6] (p. 2146)). SW and SH are thus intended to serve as effectiveness,
not as equity measures ([5] (p. 101)).
Yet, their approach does not live up to its task, since neither the SW nor the SH metric
is as normatively innocuous as Michaelowa et al. seem to assume, as the present paper
demonstrates. The basic problem of both measures is that they compound descriptive
elements of money or health saved on the one hand (effectiveness) with distributional
considerations as to how the units of value saved should be distributed among the persons
concerned when it comes to adaptation funding decisions on the other (equity). In effect,
SW and SH may end ethical and political debates, albeit not by solving them, but by
hiding critical normative assumptions in highly aggregated numbers. As the use of these
indicators does not enhance but diminishes transparency of decision making, they should
at best be used with great caution as adaptation metrics.
To support these claims, the argument proceeds as follows. The ensuing section deals
with the SW indicator and analyzes Michaelowa and colleagues’ arguments for using
relative and absolute economic savings as measures for adaptation benefit (Section 2). In
doing so, I will argue, first, that they reject a “purely” economic approach, focusing only
on the economic benefits of adaptation projects, for the wrong reasons; second, that the
measure of relative economic savings does not accomplish what the authors intend it to;
and third, that the justification of combining absolute and relative economic savings is
conceptually unsound and ultimately unconvincing. While, in general, (philosophical)
problems of CBA are quite well-known in environmental ethics and the climate change
debate [8,9], the same cannot be said for the discussion on the use of summary measures of
population health within CEA; Michaelowa and colleagues hardly discuss the DALY at all.
To fill this lacuna in the literature on climate change, the better part of this paper critically
examines the DALY (Section 3). After outlining the theoretical basics of the measure, three
important steps of the DALY’s theoretical development since its inception in 1990 will
be sketched to demonstrate that the DALY is not ethically innocuous. What is especially
troublesome is the amalgamation of concerns for the descriptive measurement of health
on the one hand and of distributional concerns of how health care should be allocated
on the other hand. As serious conceptual and ethical issues still remain unsolved, the
DALY does not meet the demands made by Michaelowa et al. Note that by undertaking a
close analysis of the specific arguments presented by Michaelowa et al., the paper makes
a general contribution to the debate on climate change adaption finance and adaptation
metrics, since the authors’ defense of the SWSH approach raises some general problems of
economic evaluations, summary measures of population health, and resource allocation.
The paper concludes that SW and SH should only be used with great caution as adaptation
metrics (Section 4).
Beforehand, three clarificatory remarks are in order, the first two of which concern
the aim and scope of the paper (I am grateful to two anonymous reviewers for pressing
me on these points). First, it is beyond this paper’s scope to propose alternative solutions
to the difficult questions of how adaptation should be measured and how adaptation
funding should be allocated. It contributes to these debates, though, by proposing an
elaborate analysis of universal metrics and, thus, providing a basis for further research on
the matter. Second, I appreciate the fact that Michaelowa et al.’s paper serves the same
function of enhancing the debate and I am sure they themselves were aware of the problems
their SWSH approach is facing. By criticizing it, I am taking up the ball and take their
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contribution seriously. The final remark concerns the concept of “adaptation finance.” I
will use this term broadly and will not differentiate between different sources or levels of
funding, since these differences do not seem to impact the fundamental normative analysis
of summary measures undertaken here. However, they certainly will make a difference
when it comes to the need for and the normative consequences of using universal metrics.
This is an important topic for further research.
2. Saved Wealth: Absolute and Relative Savings
2.1. Absolute Wealth and Cost–Benefit Analysis
The first metric for measuring the effectiveness of climate adaptation projects proposed
by Michaelowa et al., SW, is itself a product of two indicators, saved absolute and saved
relative wealth. The former measures the absolute wealth of a community saved by the
adaptation project, adjusted by purchasing power parity when it comes to international
comparisons ([4] (p. 10), [5], (p. 2150)). This is the classical approach of CBA, which defines
all benefits of a certain project in terms of money. If the benefits in question cannot be
assigned a market value, a method called contingent valuation is used to mimic the market
valuation process ([10], (p. 2f.)). Thereby, respondents are asked for their willingness to pay
(WTP) for some hypothetical alternative presented to them (such as saving an endangered
species) or the sum of money they would regard as compensation for forgoing the option
(e.g., for letting the species become extinct). If the accumulated WTP values outweigh a
project’s costs, the respective policy is regarded as efficient.
Michaelowa et al. reject CBA’s measure of value as sole aim of adaption projects for
three reasons. First, they claim that CBA cannot account for “non-monetized” benefits, such
as some social and environmental benefits ([5] (p. 111)). Second, they criticize contingent
valuation by arguing that the elicited WTP depends on the person’s ability to pay, which,
in turn, hangs on a country’s wealth, so resource allocation in climate adaptation based
on CBA would systematically disfavor the most vulnerable countries ([5] (p. 111)). Third,
they regard the matter of assigning a monetary value to human life as too contentious ([6]
(p. 2149)). In the following text, each of these objections will be considered in some detail.
The present Section 2.1 deals with the first, the following section deals with the second
objection (Section 2.2), and the third will be examined comprehensively in Section 3.
Regarding the first criticism, i.e., CBA’s restriction to “economic benefits” ([6] (p. 2148)
and its disregard of “non-monetized” benefits ([5] (p. 111)), it remains unclear what exactly
the authors have in mind. That CBA simply looks at “economic benefits” is certainly
true, but then again, from the perspective of CBA, anything of value can be considered an
economic benefit since anything can be assigned a monetary value. Hence, Michaelowa
et al. either must consider “absolute economic savings” only in terms of actual money
and goods that already “come with” a market value, or their criticism is not that CBA
cannot incorporate non-monetized benefits, but rather, that it should not. The first option
would require some specification of which values should enter the economic benefit in
question. After all, the value of real estate, for instance, is also an estimate of what others
would be willing to pay for it, if it were sold. In any case, this option seems not to be what
Michaelowa et al. mean, as absolute savings are supposed to include public infrastructure,
“which can include natural resources and services” ([4], (p. 10)). Thus, they seem to regard
some environmental impacts, such as the loss of biodiversity, as too “difficult to measure
in terms of monetary wealth” ([4] (p. 9)). However, since they do not spell out what “too
difficult” means, it seems to be an ad hoc decision which benefits to express in monetary
terms and which to consider qualitatively.
It needs to be stressed at this point that the question of which benefits—and which
costs, for that matter—to include in CBA is no mere technical issue, but a normative-ethical
one ([11] (pp. 166–176)). Theoretically, CBA is supposed to be “as all-encompassing as
possible” when it comes to the valuation of costs and benefits, i.e., it is meant to adopt
a social perspective ([11] (p. 168); see also [12] (pp. 11, 15). Yet, since not each and every
cost and benefit, including future ones, can possibly be considered, some limitation has
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to be made. In practice, this restriction often is not only pragmatically but also ethically
motivated. When it comes to health care, for instance, applied CBA usually disregards “the
indirect benefits of increased production” stemming from improved health ([13] (p. 794).
As to the choice of which costs to consider, the following example taken from Garber
et al. is illustrative of its ethical dimension: “Suppose, for example, that we contemplate
instituting a suicide prevention program in high school. It is highly effective and reduces
teenage suicides by 50%. Students who would otherwise have died now lead lives of
average length and have medical care utilization comparable to those of average persons
of their age. Should the future cost of health care that they consume be counted as costs of
the intervention?” ([14] (p. 45)).
I guess most of us would answer in the negative. Obviously, by excluding some
values ad hoc, the value-maximizing logic of CBA is not strictly adhered to in praxis,
which suggests that something may be wrong with this logic in the first place. Coming
back to Michaelowa and colleagues, they seem hesitant to incorporate all environmental
impacts into the CBA of adaptation projects as well. I surmise that the respective problem
does not consist in the technical difficulty of measurement, though, but rather points to
normative-ethical issues of CBA. Put differently, the real question is not whether all benefits
can be assigned a monetary value but whether they should. In effect, Michaelowa et al.
mask the normative decision not to include some adaptation benefits as a technical one.
As a second objection leveled against CBA, the authors criticize that allocating re-
sources with the aim to maximize absolute wealth saved not necessarily addresses vulner-
ability. (The authors do not define “vulnerability” in more detail and neither will I. For
the complex connection between wealth and vulnerability in the context of prioritizing
adaptation projects, see [15] (p. 604f).) In fact, it is likely that the opposite is true, since
the richer a country is, the less vulnerable to climate change its inhabitants tend to be,
but the more absolute savings are possible ([5], (p. 115))— “Where more valuable objects
[ . . . ] exist, more can be lost” [16], (p. 82)). Note that in contrast to the aforementioned
criticism, this objection against CBA does not refer to its monetary measure of benefit but
to the ethically undesirable consequences of allocating adaptation funding with the aim of
maximizing this benefit. That is to say, it stems from concerns for distributional equity.
Before discussing Michaelowa et al.’s proposed remedy, another question presents
itself: In light of their objections leveled against CBA, why do the authors not generally
reject absolute wealth saved and replace it with another measure? Somewhat surprisingly,
Stadelmann et al. state that “absolute economic value has its own merits: it is the usual
way to measure macro-economic effectiveness, it is a standard indicator for evaluating
the well-being of societies, it reflects overall utility as stated by market participants, and,
finally, vulnerable people may benefit from absolute economic assets via redistribution”
([5] (p. 111)). We are thus presented with four reasons for not dropping absolute economic
value. The first and the second reason given boil down to the claim that economic value
is commonly used to assess aggregate well-being. Yet, the mere fact that some measure’s
use is widespread does not mean that using it is warranted ([16] (p. 82)). As to the third
supposed merit of economic value, it remains unclear in which respect it differs from the
second, for within applied welfare economics, “overall utility” is usually equated with
well-being. That being said, regardless of whether “utility” is understood in terms of
(some kind of substantive) well-being or of preference satisfaction, it is well established
in the literature by now that there is neither a proportional relationship between GDP
and well-being nor one between the satisfaction of market preferences and any kind of
substantive well-being ([17], (pp. 77–87)). Michaelowa et al.’s reasons two and three thus
do not stand critical scrutiny. Finally, more economic assets do indeed potentially allow
for more redistribution so that the poor could indirectly benefit from absolute economic
savings. Then again, this argument is reminiscent of the so-called “trickle-down theory,”
popular in the 1990s, according to which the wealth of a few will ultimately trickle down
to the less fortunate in society—a hope that proved unwarranted. Beyond that, if the
merit of considering absolute savings ultimately consists in its (potential) contribution
Sustainability 2021, 13, 9428 5 of 14
to alleviate vulnerability via (hypothetical) redistribution, why not focus on vulnerability
directly or, at least, on more objective measures of well-being and resilience, bypassing
the problems associated with CBA altogether? All in all, the arguments for considering
aggregate absolute economic value even as a part of the equation remain unconvincing.
2.2. Relative Wealth
Instead of dropping the metric of absolute saved wealth, Michaelowa et al. argue that
the trade-off between saving wealth and tackling vulnerability can be eased by combining
absolute with relative wealth saved, which is the absolute wealth saved by a project divided
by the total wealth of the respective community ([4] (p. 10)). Since the same amount of
monetary benefits saved constitutes a larger fraction of income for the poor than for the
rich, aiming at saving relative wealth favors poorer regions, they argue, so that it indirectly
considers vulnerability. Stadelmann et al. differentiate between an individual-level and an
aggregate assessment of relative wealth saved ([6] (p. 2150)). While applying the former
would be preferable, lack of data and privacy protection render this option infeasible, so
they propose using the relative wealth concept on an aggregate basis.
However, once an aggregate assessment of relative wealth saved takes place, most
of the asserted advantages of this concept vanish. The claims that “the relative savings
indicator measures the number of personal livelihoods that can be saved” ([5] (p. 114))
or that relative wealth saved addresses inequalities in wealth and vulnerability within
communities ([4], (p. 10)), for instance, only hold if a project’s impact on each individual
is considered separately. Aggregated data, by contrast, do not tell anything about the
distribution of the respective losses within the community. This is highly relevant, because
“losing, say, 10% of one’s income might impose serious hardship on a poor person while
it does not [do so] for a very wealthy member of society” ([16] (p. 83)). Therefore, saved
wealth fails to tackle social inequalities within one community.
Beyond that, the aggregated relative saved wealth indicator may lose its significance
when it comes to the comparison between communities as well. To see this, consider
the example given by Köhler and Michaelowa of a community of 1000 people and a
total wealth—or GDP—of USD 1 million ([4] (p. 2)). If an adaptation measure saves this
community USD 0.2 million, the relative saving amounts to 20%. To be sure, if USD 0.2
million is spared in a community with the same number of inhabitants with a GDP of
USD 10 million, the relative saving is only 2% and the indicator would favor the poorer
area. If, however, the richer community also stands to save more absolute wealth in virtue
of the adaptation project, let us say USD 2 million, the relative savings are the same and
vulnerability is not tackled at all. Aggregated sums cannot, in principle, take distribution
into account.
Finally, even if an allocation of resources focusing on maximizing saved relative wealth
would favor poorer communities, it is unclear to which extent alleviating poverty lessens
vulnerability. After all, poverty or lack of income cannot be equated with vulnerability,
since irrespective of its specific definition, the latter certainly also depends on other factors,
such as “the extent of people’s dependency on risky activities and sources of income such
as agriculture and fishing” ([15], (p. 605)). Thus, whether SW accounts for vulnerability at
all depends on a project’s specific context, a fact that renders its usefulness as a universal
adaptation metric questionable. (Note that the fact that the climate change vulnerability of
a certain region is by definition geo-localized does not in general undermine the search for
universal metrics. For once a measure for vulnerability was defined, this could be applied
to different adaptation projects across different regions. I am grateful to an anonymous
reviewer for raising this point.)
In sum, the SW indicator is not successful in addressing the first two objections leveled
against CBA by Michaelowa et al. The following section analyzes whether the DALY
provides for a satisfying solution to their third issue with CBA: the controversial matter of
assigning a monetary value to human life ([6] (p. 2149)).
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3. Saved Health: The DALY
3.1. Saved Health and Cost-Effectiveness Analysis
Incorporating the prevention of ill-health and premature death into a climate change
adaptation measure is certainly plausible (for the critical relevance of public health data
for the (public) debate on climate change, see [9]). The question is how to define and
measure ill-health, though. In this respect, Michaelowa and colleagues endorse the DALY.
The justification given for this theoretical choice mainly refers to the drawbacks of other
approaches and the public rejection of attaching monetary values to human life. Traditional
methods to do so make the value of a human life contingent upon the respective person’s
income. The human capital approach, for instance, determines “the pay-back” on the
“investment” in human capital as the present value of the individual’s future earnings,
using market wage rates ([18] (p. 215f.)). This is especially troublesome when it comes to the
comparison of data for industrialized and developing countries, which is common practice
in the discourse on climate change ([4] (p. 3)). Michaelowa and colleagues reckon that since
monetary valuation of life is “fraught with ethical and political challenges” ([7] (p. 67)), it
“should be avoided, especially if comparing industrialized and developing countries” ([6]
(p. 2152)). To escape the “endless political debates about an equitable valuation of human
life and death” ([6] (p. 2149) it would be critical “to have a non-monetary indicator that
addresses the health benefits of adaptation projects” ([7] (p. 67); see also [4] (p. 9)).
Considering non-monetary benefits, Michaelowa and colleagues shift from CBA to a
form of CEA, which defines the benefit measure in terms of some unit other than money,
usually some physical target ([12] (p. 16)). In health care, this could be reduction in blood
pressure in mmHg. Although such physical measures appear straightforward and easy
to understand, they obviously do not allow for comparing the efficiency of projects with
different goals. At this point, generic measures of health, such as DALYs or quality-adjusted
life years (QALYs), enter the scene, which allow to capture both premature mortality and the
reduced quality of life due to ill-health. The DALY does so by combing the number of years
of life lost (YLL) with the number of years lived with disability (YLD). The term “disability”
is used in a broad sense here and denotes any short- or long-term loss of health ([19]
(p. 2198), [20] (p. 2130)). To measure the YLDs, each year lived with a disability is attached
a disability weight, where 0 represents perfect health and 1 expresses death or a condition
equivalent to death. Being a measure of ill-health and life lost, the DALY is not a “good”
to be saved or maximized but a “bad” to be minimized ([21] (p. 307)). (The terminology
“disability-adjusted life-year” is misleading, since, to speak with Anand/Hanson [21]
(p. 310), “more of a ‘life-year’ (even adjusted for disability) is normally understood as a
‘good’, which should be maximized and not minimized.” Accordingly, there exists some
confusion on this matter in the literature on climate change as well, for instance, when
Köhler and Michaelowa speak of the “the concept of Disability Adjusted Life Years (DALYs)
saved” ([4] (p. 3); see also [5] (p. 111)). In an otherwise illuminating paper, Nolt describes
the DALY consistently wrong when he claims that “[o]ne DALY is one year of healthy life.
[ . . . ] [E]ach disability is assigned a value between 0 (death) and health (1), lower numbers
representing greater severity” and so forth ([9] (p. 351)). What he says is right—though not
with respect to the DALY but for its close relative, the QALY.).
Michaelowa and colleagues hardly discuss the DALY, but their reasons for using it
quoted above suggest that the authors consider the DALY as not being fraught with ethical
challenges and as not prompting political debate. Due to the DALY’s lack of transparency,
the latter claim may indeed be correct ([9] (p. 351)), but the former is far from true. To see
this, a closer examination of the DALY and its measurement is illuminating.
The DALY was developed during the first Global Burden of Disease (GBD) study 1990,
launched inter alia by the World Health Organization (WHO), with the purpose of esti-
mating the global burden of health loss due to diseases, injuries, and risk factors (such as
tobacco use or high blood pressure) differentiated by age, sex, and geographical region.
Adjacent to providing a unit of measurement for monitoring the global burden of disease,
the DALY is also intended to serve as an outcome measure within CEA ([22], (p. 704)).
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It seems fair to say that the DALY is for public health what a universal metric would be
for climate change adaptation. Since the beginning, however, the DALY has ignited a
critical debate on its theoretical and methodological foundations and has undergone crucial
modifications [21–29]. In the following text, the debates on the central issue of what the
DALY is supposed to measure in the first place will be illustrated by considering three
important steps of the DALY’s development within the GBD framework. The purpose of
this endeavor is twofold: for one thing, the analysis supports the thesis that the DALY
incorporates lots of controversial normative assumptions. For another, it will become
clear that the construction of the DALY as a descriptive measure of ill-health is already
heavily influenced by distributional considerations—just as the SW metric proposed by
Michaelowa et al. is.
For the measurement of disability weights, preliminary considerations on the DALY
proposed six disability classes describing some condition in general terms, an example
being the following: “[L]imited ability to perform activities in two or more of the following
areas: recreation, education, procreation or occupation” (class 3) or “[n]eeds assistance with
activities of daily living such as eating, personal hygiene or toilet use” (class 6) ([23] (p. 438,
Table 2)). These classes were evaluated by a group of medical experts by means of a method
called magnitude estimation ([23], (p. 439)), which asks the respondents a question of the
form “How many times worse is one state than another [reference] state?” ([30] (p. 16)).
In this way, class 3 was assigned a weight of 0.400 and class 6 a weight of 0.920. Each
disability class was supposed to represent “a greater loss of welfare or increased severity
than the class before,” and the weights were intended to measure a disability’s “impact
on the individual” ([23] (p. 438)). However, the disability weights were not supposed to
measure the myriad ways in which a health state affects individual well-being (the intricate
relationship between “health” and “well-being” and the question of what should be tackled
by means of summary measures of population health has been discussed extensively by
Hausman [17]), for such an account would have to take into account the social context
of the respective individual ([23] (p. 437f.)). Instead of tackling the specific disadvantage
caused by a health state, the disability classes and, hence, the weights were supposed to
represent the disability in terms of human functioning ([23] (p. 438)).
This individualist perspective was thwarted by two other normative choices, though.
First, to determine the YLL, the designers of the DALY applied a maximum life expectancy
of 82.5 years for women, which equaled the life expectancy for women in Japan, the country
with the highest life expectancy worldwide ([22] (p. 711)). For men, the maximum life
expectancy was set to 80 years, where the divergence was supposed to mirror different life
expectancies due to biological factors, not lifestyle choices ([22] (p. 711)). A standardized
life expectancy was applied globally because it should not be considered “more important
to save the life of a person in a rich country (with greater life expectancy) than to save the
life of someone in a poor country” ([28] (p. 201)). Both choices can be criticized. For one
thing, and as pointed out by Lyttkens (ibid.), if “biologically” different life expectancies
are taken into account in the case of sex, why not also consider such differences between
other social groups, once they are detected? As to the application of a universal life
expectancy, it can be argued that it is beside the point to claim that a man living in Sierra
Leone and dying at the age of 30 due to a certain disease loses 50 DALYs attributable
to the respective disease, while his life expectancy had only been 38 years anyway ([26]
(p. 5)). (The 38 refers to 1997, the year Murray and Acharya’s paper was published. In
2018, according to the World Bank, the life expectancy in Sierra Leone was 54.309 years.
See https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=SL, accessed on
24 August 2020.) While driven by plausible distributional considerations, the use of a
universal life expectancy is thus problematic when it comes to the descriptive measurement
of the burden of disease due to specific diseases or risk factors.
The second normative choice of concern here refers to differential valuations of the
DALY prohibited at different ages, the value being highest for young adults around the
age of 25 and lowest for both children under 10 and the elderly over 60 years ([23] (p. 436)).
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The reason for attaching age weights to DALYs is stated by Murray as follows: “Higher
weights at a particular age does [sic] not mean that the time lived at that age is per se more
important to the individual, but because of social roles the social value of that time may be
greater” ([23] (p. 435)). Young adults, so the idea, play an important role “in providing for
the well-being of others” (ibid., see also [22] (p. 718)). That is to say, the well-being of the
most vulnerable is supposed to be accounted for by attaching a higher value to the health of
those who care for them. (Since I suppose that discussions about discounting future benefits
are well known in the adaptation literature, I do not elaborate upon discounting future
DALYs here. See [26] (pp. 695–98) and [29].) This is highly problematic, though, especially
for two reasons. First, this reasoning opens Pandora’s box, as Lyttkens ([28], (p. 200)) put
it, since it implies that a higher value would have to be attached to the health of doctors,
nurses, or other persons providing care and crucial services for others as well, whereas
the health of persons without children or elderly dependents to take care of would have
to be assigned a lower value ([25], (p. 692)). The same would be true for chronically ill or
disabled adults who require care. This seems to be an ethically unacceptable consequence.
Second, age weighting based on social considerations, along with using universal life
expectancies, introduces distributive considerations as to who should receive priority when
it comes to treatment into the DALY, so the resulting number cannot be regarded a purely
descriptive measure of ill-health.
For the final GBD 1990, some aspects of the DALY were reconsidered ([22,24]). While
age weighting and a universally high life expectancy were adhered to, the question of what
to measure was now answered unambiguously regarding a social evaluation of health: “It
can be argued that for burden of disease [ . . . ] and cost-effectiveness analyses that are
intended to inform social choices, a method that directly measures social preferences for
health states would be more appropriate than one that measures individual preferences”
([22], p. 713). In this context, social preferences are preferences individuals have not with
regard to their own health but concerning the distribution of health or health care on other
persons, not including themselves ([31], p. 26).
These social preferences were elicited by means of the person trade-off (PTO) method
from a group of health care providers from each region of the world convened at the
WHO in 1995 ([22] (pp. 713, 715)). The respondents were confronted with two version
of the PTO. In the first version, PTO1, they were asked to compare life extension for a
healthy individual with life extension for a person with a disability: “[W]ould you as
decision maker prefer to purchase, through a health intervention, 1 year of life extension
for 1,000 perfectly healthy individuals or 2000 blind individuals?” ([22] (p. 714)). In a
series of such questions, it was elicited how large the number of blind persons must be so
that the respondent is indifferent between the two scenarios. If the number is, say, 8000,
the disability weight would amount to 1 minus 1000 divided by 8000, that is, 0.875 ([32]
(p. 1424)). In the second version of PTO, PTO2, the respondents were asked to compare the
value of curing a certain number of individuals with disabilities on the one hand with life
extension for a certain number of healthy persons on the other: “[H]ow many people cured
of blindness do you consider equal to prolonging the lives of 1000 healthy people?” ([32]
(p. 1424)) If the disability weights derived from PTO1 were inconsistent with those inferred
from PTO2, the respondents were instructed to reconcile their answers ([24] (p. 36)).
However, it is questionable whether different weights resulting from the two PTOs
present an inconsistency in the first place, since they ask for quite different things. Consider
PTO1 first: the question assumes that a life-year gained for (or better: in) a disabled
person is of less value than a life-year gained in an otherwise healthy person. Yet, the
respondents might believe that both groups of persons have equal claims to the life-saving
procedure ([32] (p. 1424)). In terms of value, this means that they regard prolonging the
life of 1000 healthy persons and prolonging the life of 1000 disabled persons as equivalent.
This, however, implies a disability weight of zero, which means that a blind person counts
as perfectly healthy and has no claim to health care when it comes to resource allocation.
This is why such results were considered irrational. The problem here, again, is that the
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task of descriptively evaluating how bad a health state is for the respective individual is
meshed up with distributional considerations about resource allocation. Note that at this
point, we are back to the very problem of valuing human lives, which Michaelowa and
colleagues were so eager to evade by using the DALY in the first place.
PTO2, by contrast, does not entail any devaluation of life-years gained by a certain
group of patients and might therefore lead to a different disability weight for the health
state at stake. In effect, the respondents might interpret the PTO1 scenario as an issue
of distributive justice, that is, social value, whereas they might read PTO2 as asking for
their evaluation of the health state in question, i.e., individual value (see also [28] (p. 197)).
Asking the respondents to resolve the apparent inconsistency not only forces them to attach
less weight to life-years gained for the disabled but also renders the resulting disability
weights meaningless ([32] (p. 1424), [27] (p. 121)).
In the course of the GBD 2010, the DALY’s conceptual, normative, and methodological
foundations have been substantively revisited ([19]). To begin with, the GBD now decidedly
seeks “to quantify health loss rather than welfare loss” ([20] (p. 2130)) so that the disability
weights are taken to “reflect the general population judgment about the ‘healthfulness’ of
defined states, not any judgments of quality of life or the worth of persons or the social
undesirability or stigma of health states” ([33] (p. 12)). Accordingly, the age weights have
been dropped, whereas the application of a universal life expectancy is still adhered to ([19]
(p. 2199)). (Life expectancy is no longer differentiated between men and women, though,
and YLL are calculated using a new reference-standard life expectancy at each age.) For
measuring the “healthfulness” of different health states, two new methods were developed,
and the respective questions were answered by a sample of the public from all over the
world. To be able to discuss what the methods elicit, the questions need to be considered at
length. The first method, a paired comparison, looks as follows:
“Now, we want to learn how people compare different health problems. [ . . . ] I
will ask you to tell me which person you think is healthier overall, in terms of
having fewer physical or mental limitations on what they can do in life. [ . . . ]
There are no right or wrong answers to these questions. Instead, we are interested
in finding out your personal views.
The first person [[ . . . ] has mild tremors and moves a little slowly, but is able to
walk and do daily activities without assistance.
The second person [[ . . . ] has some trouble remembering recent events, and finds
it hard to concentrate and make decisions and plans.
Who do you think is healthier overall, the first person or the second person?” ([34]
(p. 2)).
While this type of question focuses on chronic disabilities, the following, so-called
population health equivalence method, draws on the PTO and seeks to elicit trade-offs
between mortality and non-fatal health states:
“The last questions will ask you to compare the overall health benefits produced
by two different programs. Imagine there were two different health programs.
The first program prevented 1000 people from getting an illness that causes rapid
death.
“The second program prevented [Number selected randomly from {1500, 2000, 3000,
5000, 10 000}] people from getting an illness that is not fatal but causes the
following lifelong health problems: [[ . . . ] Some difficulty in moving around,
and in using the hands for lifting and holding things, dressing and grooming.
Which program would you say produced the greater overall population health bene-
fit?” ([34] (p. 3))
Whereas the first question asks the respondents whom of two patients they consider
“healthier overall,” the latter asks them for the program producing “the greater overall pop-
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ulation health benefit” (ibid.). This way of eliciting disability weights is highly problematic,
though, and there are three reasons why.
First, regarding the population health equivalent, the authors stress that they do not
want to mesh up the measurement of health on the one hand with distributional issues on
the other when they state, “In keeping with the focus in the GBD 2010 on the construct of
health loss, we explicitly avoided framing of the question in terms of resource allocation
decisions, as this framing may evoke distributional concerns that are orthogonal to the
health construct” (ibid.). While it is true that they do not explicitly ask the respondents
to make a (hypothetically) distributional decision, neither do they ask them to imagine
themselves in the respective health state. Instead, they choose a consequentialist account
that asks for some abstract sum of health aggregated above all persons concerned. In
doing so, the question presumes that the respondents are able and willing to evaluate
abstract units of health, add these values up, and draw a balance sheet across the patients
concerned. Yet, this consequentialist manner does not seem to be the most natural way to
understand the population health equivalent. Most likely, the respondents do not think of
the “amount” of health produced by each program, but rather regard it as a distributional
task, which makes them consider which program should be realized and, thereby, which
group of patients should be treated.
Second, without considering the impact of health on well-being or quality of life, it is
conceptually unclear what it means to say that one of two persons is “healthier overall.”
Health is a multidimensional concept, and different health states imply quite different
limitations on what one can do. These differences cannot simply be measured in terms
of “more” or “less.” To see this, try to figure out who is healthier in terms of facing fewer
limitations on what he or she can do: (i) a person sitting in a wheelchair, (ii) a blind person,
(iii) a person suffering severe migraine attacks two or three times each month, or (iv)
a person with arthrosis and constant pain in the joints. Considering this question, two
conclusions can be drawn. First, without balancing the different dimensions of health
somehow, it is impossible to tell who is healthier as such. In addition, while it is possible to
say whether one person is healthier than another as long as only one dimension is at stake
(e.g., a person blind in one eye is “healthier” than a person blind in two eyes), the relevance
of such comparison is rather limited. This is because, second, the severity of the limitations
associated with a health state depends on the latter’s effect on the person’s quality of life
and socially available activities and on an assessment of the relative importance of these
activities ([17] (pp. 54f.)). Hence, health as such cannot be quantified but must be valued
([17], p. 42).
Third, and intricately connected with the aforementioned issue, it is impossible to
separate the valuation of health from the social context. This claim can be substantiated by
considering an example taken from Voigt and King [35]: Imagine two countries with equal
numbers of persons with impaired vision. In one country, corrective lenses are available,
so the persons concerned hardly suffer any negative consequences from their condition
at all. In the other country, by contrast, there are no corrective lenses and persons with
impaired vision have difficulties finding jobs, gaining a sufficient income, and so forth. The
designer of the GBD 2010 in effect argue that although the impact of impaired vision on
well-being may vary between those countries, the health state as such does not, and this is
the invariant construct they want to measure. However, even if one is willing to consider
the persons in both countries as equally healthy, when it comes to allocating resources, it
seems reasonable to say that it should make a difference of how their health state actually
affects their life ([35] (p. 227)).
To conclude, measuring units of health as such is impossible and asking the respon-
dents to compare programs in terms of the overall population health benefit presupposes a
framework they are not accustomed with. While I argued that the respondents probably
understand the population health equivalent as a distributional choice, the meaning of their
answers to the paired comparisons and, thus, the respective disability weights remains
obscure ([36], [17] (p. 42)).
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3.2. Implications for SH
To sum it up until this point, the previous subsection illustrated that the DALY’s de-
velopment has been accompanied by critical debates on and modifications of its conceptual
and normative foundations. The designers of the GBD 2010 tried to react to criticism leveled
against the DALY, but their proposals remain unconvincing. The contentious normative
choices incorporated in the DALY and the problematic methods to elicit disability weights
not only call into question what the DALY measures, especially whether it tackles the
individual value of health or distributional goals, but also reveal that it is by no means
an ethically innocuous measure of health. Instead of enhancing the transparency of the
decision-making process, such a heterogeneous and highly aggregated measure in fact
diminishes intelligibility by hiding controversial value judgments ([29]). This is a highly
relevant insight when it comes to the SH indicator, for the DALY obviously does not live
up to the task of avoiding ethical challenges, as Michaelowa and colleagues assumed it
would. In addition to this fundamental issue, I want to point out some further problems of
their use of the DALY as an SH indicator and, in doing so, draw some general conclusions
as to the DALY’s usefulness.
First, Stadelmann et al. take the DALY to measure human lives savings due to some
adaptation project ([5] (p. 111)). As we saw, however, the DALY is a product of YLL
and YLD, and it is impossible to know whether saving some number of DALYs means
saving any life at all. The number could as well represent the prevention of a lot of minor
disabilities. This ambiguity of the DALY raises the question of whether death and non-fatal
health states should be compounded within one number in the first place ([25] (p. 689)), for
it arguably makes a difference whether a project saves lives or prevents deteriorations in
health.
For a similar reason, second, the claim that SH is a proxy for reduced vulnerability ([5]
(p. 111) is not necessarily true. Around 1,300,000 DALYs could be saved by curing cellulitis
([19] (p. 2208, Table 1)), but would this reduce vulnerability? Allocating adaptation money
strictly so as to maximize the sum of DALYs prohibited may well lead to systematically
disadvantaging those who are already worse off ([15]). These first two aspects together
call for a disaggregation of the data and the value judgments incorporated in the DALY in
order to enhance the transparency of the decision-making process ([29]).
Third, Michaelowa and colleagues search for a measure that does not put different
values on the lives of rich and poor persons (see e.g., [5] (p. 111)). When it comes to
calculating the YLL, Stadelmann et al. point out that the choice of reference region is “an
ethical issue”: “From an equity viewpoint, the average global life expectancy should be
chosen, whereas from a comparative economic view, the locally applicable life expectancy
would be preferred” ([6] (p. 2153)). Why the first alternative would be a demand of equity
and the second one of economics remains unclear, though. In their case study in Vietnam,
Köhler and Michaelowa [4] choose the local life expectancy of Vietnam (74.2 years) to
calculate the YLL. Since the respective CEA concerns two different projects in the same
region, this choice does not really matter, but it would be interesting to know which life
expectancies the authors would propose for international comparisons.
However, even if the same life expectancy was used, fourth, the question arises as
to whether the DALY with its focus on health instead of well-being actually provides a
universal metric at all, for using the DALY as a benefit measure within CEA may hamper the
equal consideration of persons living in poor and those living in rich countries in another
respect. As we saw by considering the example of corrective lenses, the social context of a
person crucially influences what some health state means for the patient. The context in
question incorporates not only technological possibilities and medical infrastructure but
also “softer” social factors such as the support ill or disabled persons receive from their
community. Hence, it could be argued that a DALY saved in Germany does not represent
the same burden of disease as a DALY saved in the Democratic Republic of the Congo. All
in all, the considerations presented here show that it may be doubted whether Michaelowa
et al. indeed gain much by avoiding to put a price tag on human life, because relative
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evaluations of life and health happen anyway once the value-maximizing perspective of
CEA is adopted (for a similar point, see [11] (pp. 176–78)).
4. Conclusions
This paper analyzed the SW and SH indicators that were recently proposed by
Michaelowa et al. as universal adaptation metrics. While SW incorporates saved ab-
solute and saved relative weights, SH is represented by the number of DALYs prohibited
due to a particular adaptation project. As both measures are general and highly aggregated,
they are supposed to serve both as descriptive measures to monitor and evaluate the
success of adaptation projects ex post and as input into CEA to determine cost-effective
projects ex ante. I argued that neither of these measures lives up to its task. As to SW,
relative wealth saved would only tackle the poor if the effect of an adaptation project
would be estimated for each individual separately. Once aggregate data are used, the
sum of relative wealth saved is just as distributional insensitive as the sum of absolute
wealth is. Beyond that, the attempt to account for vulnerability by modifying the benefit
measure within CBA introduces distributional considerations of justice into the definition
of the units of value. This does not only run counter to Michaelowa et al.’s asserted ethical
modesty but also diminishes transparency of decision making. Finally, the arguments
presented by the authors for complementing as opposed to substitute absolute savings
with relative savings is not convincing. I have raised similar concerns regarding the DALY
as a measure of ill-health. As the sketch of the DALY’s theoretical development illustrates,
it is still contested in the literature what the disability weights are supposed to represent at
all. The debates around the use of a certain life expectancy and the different weightings
of DALYs according to the age of the recipient reveal that the DALY also suffers from an
insufficient separation between the measurement of (the value of) health on the one hand
and the question of how health and health care should be prioritized and distributed on
the other hand.
Hence, although highly aggregated summary measures such as the DALY are usually
praised as allowing for transparent and fair decision making, they pose the danger of
hiding controversial normative assumptions, treating them as mere technical issues, and
thus withdrawing them from public discourse. The sum of economic savings or DALYs
generated by a project, in turn, also disguises how DALYs are distributed on the persons
concerned and how individuals are treated. The “ethical and political challenges” asso-
ciated with measuring what is valuable for human beings in different societies and with
distributing resources fairly cannot be evaded and must not be concealed.
Where does this leave us? The upshot of this paper is modest but important: designing
universal adaptation metrics incorporating different adaptation aims is tremendously
difficult and may not be feasible at all. To determine whether it is, further research on
fundamental concepts, such as vulnerability, and on the role efficiency considerations can
and should play in priority setting is warranted.
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